Your account is not claimed yet. You can sign up with ORCID to claim your account.

Joon-Hyung Kim (Joon Hyung Kim)

ORCID

Publication Activity (10 Years)

Years Active: 2018-2022
Publications (10 Years): 9

Top Venues

Human vaccines & immunotherapeutics

Journal of Korean medical science

The Pediatric infectious disease journal

Pain

This page only lists publications with an associated author ORCID identifier.

Publications

Joon-Hyung Kim, Robert Johnson, Martina Kovac, Anthony L Cunningham, Mohamed Amakrane, Keith M Sullivan, Alemnew F Dagnew, Desmond Curran, Anne Schuind
Adjuvanted recombinant zoster vaccine decreases herpes zoster-associated pain and the use of pain medication across 3 randomized, placebo-controlled trials. Pain (2022)
Joon-Hyung Kim, Mamadou Drame, Thanyawee Puthanakit, Nan-Chang Chiu, Khuanchai Supparatpinyo, Li-Min Huang, Cheng-Hsun Chiu, Po-Yen Chen, Kao-Pin Hwang, Jasur Danier, Damien Friel, Bruno Salaun, Wayne Woo, David W Vaughn, Bruce L Innis, Anne E Schuind
Immunogenicity and Safety of AS03-adjuvanted H5N1 Influenza Vaccine in Children 6-35 Months of Age: Results From a Phase 2, Randomized, Observer-blind, Multicenter, Dose-ranging Study. The Pediatric infectious disease journal 40 (9) (2022)
Joon-Hyung Kim, John D Diaz-Decaro, Ning Jiang, Shinn-Jang Hwang, Eun Ju Choo, Maribel Co, Andrew Hastie, David Shu Cheong Hui, Junya Irimajiri, Jacob Lee, Edward Man-Fuk Leung, Haiwen Tang, Tomomi Tsuru, Philip Watson, Zhenhua Wu, Chong-Jen Yu, Yanfei Yuan, Toufik Zahaf, Anthony L Cunningham, Anne E Schuind
The adjuvanted recombinant zoster vaccine is efficacious and safe in Asian adults ≥ 50 years of age: a sub-cohort analysis of the ZOE-50 and ZOE-70 randomized trials. Human vaccines & immunotherapeutics 17 (7) (2021)
Romulo Colindres, Valentine Wascotte, Alain Brecx, Christopher Clarke, Caroline Hervé, Joon-Hyung Kim, Myron J Levin, Lidia Oostvogels, Toufik Zahaf, Anne E Schuind, Anthony L Cunningham
Post hoc analysis of reactogenicity trends between dose 1 and dose 2 of the adjuvanted recombinant zoster vaccine in two parallel randomized trials. Human vaccines & immunotherapeutics 16 (11) (2020)
Hee Jin Park, Sung Jin Kim, Katerina Rok Song, Jing Shen, Joon-Hyung Kim, Raghavendra Devadiga, Hee-Cheol Kang
A 6-year Prospective, Observational, Multi-Center Post-Marketing Surveillance of the Safety of Tetanus Toxoid, Reduced Diphtheria Toxoid, and Acellular Pertussis (Tdap) Vaccine in Korea. Journal of Korean medical science 34 (12) (2019)
Soon Min Lee, Sung Jin Kim, Jing Chen, Rok Song, Joon-Hyung Kim, Raghavendra Devadiga, Yun Kyung Kim
Post-marketing surveillance to assess the safety and tolerability of a combined diphtheria, tetanus, acellular pertussis and inactivated poliovirus vaccine (DTaP-IPV) in Korean children. Human vaccines & immunotherapeutics 15 (5) (2019)
Hyeongap Jang, Joon-Hyung Kim
Factors affecting influenza vaccination in adults aged 50-64 years with high-risk chronic diseases in South Korea. Human vaccines & immunotherapeutics 15 (4) (2019)
Soon Min Lee, Jang Hoon Lee, Eun-Song Song, Sung Jin Kim, Joon-Hyung Kim, Rupert W Jakes, Raghavendra Devadiga, Moon Sung Park
A 6-year safety surveillance of 10-valent pneumococcal non-typeable Haemophilus influenzae protein D conjugate vaccine (PHiD-CV) in South Korea. Human vaccines & immunotherapeutics 14 (12) (2018)
Ki Hwan Kim, Chun Soo Kim, Hwang Min Kim, Jong-Duck Kim, Sang Hyuk Ma, Dong Ho Kim, Pyoung-Han Hwang, Ji-Whan Han, Taek-Jin Lee, Joon-Hyung Kim, Naveen Karkada, Narcisa Mesaros, Woo-Yun Sohn, Jong-Hyun Kim
Immunogenicity and safety of a combined DTPa-IPV/Hib vaccine administered as a three-dose primary vaccination course in healthy Korean infants: phase III, randomized study. Human vaccines & immunotherapeutics 15 (2) (2018)

Joon-Hyung Kim.css-eqlu8i{font-size:small;padding-left:4px;} (Joon Hyung Kim)

Publication Activity (10 Years)

Top Topics

Top Venues

Joon-Hyung Kim (Joon Hyung Kim)